These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 18223681)
1. A novel HECT-type E3 ubiquitin protein ligase NEDL1 enhances the p53-mediated apoptotic cell death in its catalytic activity-independent manner. Li Y; Ozaki T; Kikuchi H; Yamamoto H; Ohira M; Nakagawara A Oncogene; 2008 Jun; 27(26):3700-9. PubMed ID: 18223681 [TBL] [Abstract][Full Text] [Related]
2. RNF43 interacts with NEDL1 and regulates p53-mediated transcription. Shinada K; Tsukiyama T; Sho T; Okumura F; Asaka M; Hatakeyama S Biochem Biophys Res Commun; 2011 Jan; 404(1):143-7. PubMed ID: 21108931 [TBL] [Abstract][Full Text] [Related]
3. Regulation of p53 localization and transcription by the HECT domain E3 ligase WWP1. Laine A; Ronai Z Oncogene; 2007 Mar; 26(10):1477-83. PubMed ID: 16924229 [TBL] [Abstract][Full Text] [Related]
4. Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate. Hastak K; Agarwal MK; Mukhtar H; Agarwal ML FASEB J; 2005 May; 19(7):789-91. PubMed ID: 15764647 [TBL] [Abstract][Full Text] [Related]
5. WW domain containing E3 ubiquitin protein ligase 1 targets the full-length ErbB4 for ubiquitin-mediated degradation in breast cancer. Li Y; Zhou Z; Alimandi M; Chen C Oncogene; 2009 Aug; 28(33):2948-58. PubMed ID: 19561640 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory role of E2F-1 in the regulation of tumor suppressor p53 during DNA damage response. Yoshihara Y; Wu D; Kubo N; Sang M; Nakagawara A; Ozaki T Biochem Biophys Res Commun; 2012 Apr; 421(1):57-63. PubMed ID: 22480684 [TBL] [Abstract][Full Text] [Related]
7. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function. Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999 [TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis by vinblastine via c-Jun autoamplification and p53-independent down-regulation of p21WAF1/CIP1. Kolomeichuk SN; Bene A; Upreti M; Dennis RA; Lyle CS; Rajasekaran M; Chambers TC Mol Pharmacol; 2008 Jan; 73(1):128-36. PubMed ID: 18094076 [TBL] [Abstract][Full Text] [Related]
9. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7. Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989 [TBL] [Abstract][Full Text] [Related]
10. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells. Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983 [TBL] [Abstract][Full Text] [Related]
11. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971 [TBL] [Abstract][Full Text] [Related]
12. A newly identified dependence receptor UNC5H4 is induced during DNA damage-mediated apoptosis and transcriptional target of tumor suppressor p53. Wang H; Ozaki T; Shamim Hossain M; Nakamura Y; Kamijo T; Xue X; Nakagawara A Biochem Biophys Res Commun; 2008 Jun; 370(4):594-8. PubMed ID: 18402767 [TBL] [Abstract][Full Text] [Related]
13. Destabilization of CARP mRNAs by aloe-emodin contributes to caspase-8-mediated p53-independent apoptosis of human carcinoma cells. Lin ML; Lu YC; Su HL; Lin HT; Lee CC; Kang SE; Lai TC; Chung JG; Chen SS J Cell Biochem; 2011 Apr; 112(4):1176-91. PubMed ID: 21308745 [TBL] [Abstract][Full Text] [Related]
14. Wild-type p53 can induce p21 and apoptosis in neuroblastoma cells but the DNA damage-induced G1 checkpoint function is attenuated. McKenzie PP; Guichard SM; Middlemas DS; Ashmun RA; Danks MK; Harris LC Clin Cancer Res; 1999 Dec; 5(12):4199-207. PubMed ID: 10632361 [TBL] [Abstract][Full Text] [Related]
15. c-ABL tyrosine kinase modulates p53-dependent p21 induction and ensuing cell fate decision in response to DNA damage. Udden SM; Morita-Fujimura Y; Satake M; Ikawa S Cell Signal; 2014 Feb; 26(2):444-52. PubMed ID: 24177958 [TBL] [Abstract][Full Text] [Related]
16. Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin. Sankala HM; Hait NC; Paugh SW; Shida D; Lépine S; Elmore LW; Dent P; Milstien S; Spiegel S Cancer Res; 2007 Nov; 67(21):10466-74. PubMed ID: 17974990 [TBL] [Abstract][Full Text] [Related]
17. Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells. Yang Y; Ludwig RL; Jensen JP; Pierre SA; Medaglia MV; Davydov IV; Safiran YJ; Oberoi P; Kenten JH; Phillips AC; Weissman AM; Vousden KH Cancer Cell; 2005 Jun; 7(6):547-59. PubMed ID: 15950904 [TBL] [Abstract][Full Text] [Related]
18. The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells. Baptiste N; Friedlander P; Chen X; Prives C Oncogene; 2002 Jan; 21(1):9-21. PubMed ID: 11791172 [TBL] [Abstract][Full Text] [Related]
19. Cooperation between ARID3A and p53 in the transcriptional activation of p21WAF1 in response to DNA damage. Lestari W; Ichwan SJ; Otsu M; Yamada S; Iseki S; Shimizu S; Ikeda MA Biochem Biophys Res Commun; 2012 Jan; 417(2):710-6. PubMed ID: 22172947 [TBL] [Abstract][Full Text] [Related]
20. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation. Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]